Synthetica Holdings

Synthetica is an AI-driven life sciences company that leverages generative artificial intelligence and synthetic data to accelerate drug discovery and development. The company's platform integrates multi-omic data and structural biology to design novel therapeutics and optimize clinical trial outcomes. By utilizing advanced machine learning models, Synthetica aims to reduce the time and cost associated with bringing new medicines to market. Their technology is applicable across various therapeutic areas, including oncology and rare diseases, where they focus on identifying high-affinity binders and optimizing lead compounds.